Myeloblast abnormalities detected by flow cytometry in 115 MDS patients
Abnormality . | N (%) . |
|---|---|
| Abnormal decrease in CD45 expression | 19 (16) |
| CD11b+ | 4 (3.5) |
| HLA-DR− | 5 (4.3) |
| Lack of CD13 or CD33 | 1 (0.9) |
| Presence of CD19, CD5, CD34, CD56, or CD7 | 26 (23) |
| Abnormal granularity | 7 (6.1) |
| Lack of CD34 | 4 (3.5) |
| Abnormal myeloid antigen intensity | 22 (19) |
| Antigenic homogeneity | 33 (29) |
Abnormality . | N (%) . |
|---|---|
| Abnormal decrease in CD45 expression | 19 (16) |
| CD11b+ | 4 (3.5) |
| HLA-DR− | 5 (4.3) |
| Lack of CD13 or CD33 | 1 (0.9) |
| Presence of CD19, CD5, CD34, CD56, or CD7 | 26 (23) |
| Abnormal granularity | 7 (6.1) |
| Lack of CD34 | 4 (3.5) |
| Abnormal myeloid antigen intensity | 22 (19) |
| Antigenic homogeneity | 33 (29) |